All Stories

  1. Establishing national hospital costing systems: insights from the qualitative assessment of cost surveillance pilot in Indian hospitals
  2. Understanding the extent of economic evidence usage for informing policy decisions in the context of India’s national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY)
  3. Health care cost accounting in the Indian hospital sector
  4. National hospital costing systems matter for universal healthcare: the India PM-JAY experience
  5. Hospital care for critical illness in low-resource settings: lessons learned during the COVID-19 pandemic
  6. Refining the provider payment system of India’s government-funded health insurance programme: an econometric analysis
  7. Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania
  8. Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic Review
  9. Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?
  10. Cost of hospital services in India: a multi-site study to inform provider payment rates and Health Technology Assessment
  11. Resource use, availability and cost in the provision of critical care in Tanzania: a systematic review
  12. Role of healthcare cost accounting in pricing and reimbursement in low-income and middle-income countries: a scoping review
  13. The role of healthcare cost accounting in pricing and reimbursement in low- and middle-income countries
  14. Essential Emergency and Critical Care as a health system response to critical illness and the COVID19 pandemic: What does it cost?
  15. A costing analysis of B-GAP: index-linked HIV testing for children and adolescents in Zimbabwe
  16. Essential Emergency and Critical Care: a consensus among global clinical experts
  17. Resource availability, utilisation and cost in the provision of critical care in Tanzania: a protocol for a systematic review
  18. Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries
  19. Cost of scaling-up comprehensive primary health care in India: Implications for universal health coverage
  20. The costs of scaling up HIV and syphilis testing in low- and middle-income countries: a systematic review
  21. Cost savings from use of a neonatal sepsis calculator in Australia: A modelled economic analysis
  22. Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience
  23. Contributions of the lay workers in providing home-based treatment adherence support to patients with advanced HIV/AIDS disease in low-income settings: Lessons learned from the field in Tanzania and Zambia
  24. Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future “test and start” strategies
  25. Cost variations in prevention of mother-to-child HIV transmission services integrated within maternal and child health services in rural Tanzania
  26. Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol
  27. Process evaluation of health system costing – Experience from CHSI study in India
  28. Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action
  29. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa
  30. Estimating the Unit Costs of Healthcare Service Delivery in India: Addressing Information Gaps for Price Setting and Health Technology Assessment
  31. Correction to: Households forgoing healthcare as a measure of financial risk protection: an application to Liberia
  32. Households forgoing healthcare as a measure of financial risk protection: an application to Liberia
  33. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: a cost-effectiveness analysis
  34. Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs
  35. Measuring income for catastrophic cost estimates: Limitations and policy implications of current approaches
  36. Determinants of health care utilisation: the case of Timor-Leste
  37. The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners: A Commentary
  38. Identification of publicly available data sources to inform the conduct of Health Technology Assessment in India
  39. The cost-effectiveness of needle and syringe provision in preventing transmission of Hepatitis C virus in people who inject drugs
  40. Identification of publicly available data sources to inform the conduct of Health Technology Assessment in India
  41. Cost-effectiveness of adding indoor residual spraying to case management in Afghan refugee settlements in Northwest Pakistan during a prolonged malaria epidemic
  42. Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling
  43. Financing for universal health coverage in small island states: evidence from the Fiji Islands
  44. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies
  45. Does integration of HIV and sexual and reproductive health services improve technical efficiency in Kenya and Swaziland? An application of a two-stage semi parametric approach incorporating quality measures
  46. Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting
  47. Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries
  48. Does integration of HIV and SRH services achieve economies of scale and scope in practice? A cost function analysis of the Integra Initiative
  49. How to do (or not to do) … translation of national health accounts data to evidence for policy making in a low resourced setting
  50. The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings
  51. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
  52. Assessment of equity in healthcare financing in Fiji and Timor-Leste: a study protocol
  53. Ten best resources for conducting financing and benefit incidence analysis in resource-poor settings: Table 1
  54. The Costs of Scaling Up HIV Prevention for High Risk Groups: Lessons Learned from the Avahan Programme in India
  55. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India
  56. Integrating public health research trials into health systems in Africa: individual or cluster randomisation?
  57. S7.4 Cost-effectiveness of targeted HIV preventions for female sex workers: an economic evaluation of the Avahan programme in Southern India
  58. What can transaction costs tell us about governance in the delivery of large scale HIV prevention programmes in southern India?
  59. The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh
  60. The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India
  61. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India
  62. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
  63. A cost function for HIV prevention services: is there a 'u' – shape?
  64. The Cost-Effectiveness of Expanding Harm Reduction Activities for Injecting Drug Users in Odessa, Ukraine
  65. 10 best resources in ... cost analysis for HIV/AIDS programmes in low and middle income countries
  66. Surviving the Impact of HIV-Related Illness in the Zambian Business Sector
  67. Is hygiene promotion cost-effective? A case study in Burkina Faso
  68. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
  69. Costs of hospital care for HIV-positive and HIV-negative patients at Kenyatta National Hospital, Nairobi, Kenya
  70. Frequent changes in policy risk confusion among health workers
  71. A systematic search of the literature on effectiveness of alliances for health promotion: some methodological issues and their implications for research